Market Place
Sourcing Support
Inhalon Biopharma`s Inhaled Antibody for RSV Entering Trials
03 Feb 2025 //
BUSINESSWIRE
Inhalon Biopharma Announces Positive Results of Inhaled Antibody Platform
20 Mar 2024 //
BUSINESSWIRE
Inhalon Announces Publications Advancing Inhaled Antibody Treatment Platform
14 Mar 2024 //
BUSINESSWIRE
Inhalon Secures U.S. Army Medical Research and Development Command Award
15 Nov 2023 //
BUSINESSWIRE
Inhalon Expands Therapeutic Horizons with Licensing of hMPV Antibodies
01 Nov 2023 //
BUSINESSWIRE
Inhalon initiates Phase I Covid-19 inhaled therapy trial
08 Oct 2021 //
CLINICALTRIALSARENA
Korean firm Celltrion developing solution to treat COVID-19 patients at home
23 Jul 2021 //
BIOSPECTRUM ASIA
Korean firm Celltrion developing solution to treat COVID-19 patients at home
23 Jul 2021 //
BIOSPECTRUM ASIA
Korean firm Celltrion developing solution to treat COVID-19 patients at home
23 Jul 2021 //
BIOSPECTRUM ASIA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.